Marsh (MRSH) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
21 May, 2026Opening remarks and agenda
The meeting was held virtually to increase inclusivity and was recorded for later access.
Management noted that forward-looking statements and non-GAAP measures may be discussed.
The agenda included director elections, executive compensation approval, auditor ratification, and a Q&A session.
Board and executive committee updates
Independent directors and executive committee members were introduced, highlighting recent leadership changes and expanded roles.
One new executive committee member joined, two took new roles, and one expanded their responsibilities since the start of the year.
Financial performance review
Total revenue grew 10% to $27 billion, with underlying revenue up 4%.
Adjusted operating income rose 11% to $7.3 billion, and adjusted EPS increased 9%.
Free cash flow reached a record $5 billion; $850 million was invested in acquisitions.
Dividend increased by 10% for the 16th consecutive year; $2 billion in share repurchases marked a company record.
Latest events from Marsh
- Q1 2026 revenue and adjusted EPS grew 8%, but legal charges weighed on GAAP results.MRSH
Q1 202623 Apr 2026 - Annual meeting to vote on directors, executive pay, and auditor ratification, all board-backed.MRSH
Proxy filing31 Mar 2026 - Strong 2025 results, robust governance, and high say-on-pay support highlight this proxy filing.MRSH
Proxy filing31 Mar 2026 - 2025 revenue up 10%, adjusted EPS up 9%, and $2.0B in share repurchases.MRSH
Q4 202527 Feb 2026 - Q2 revenue up 6%, EPS up 10%, margin 29%, and dividend raised 15% amid robust growth.MRSH
Q2 20243 Feb 2026 - Q3 revenue up 6%, strong segment growth, and $7.75B McGriff acquisition announced.MRSH
Q3 202419 Jan 2026 - Strong 2024 growth, record acquisitions, and margin expansion set up a positive 2025 outlook.MRSH
Q4 20249 Jan 2026 - Q1 2025 revenue up 9%, adjusted EPS up 5%, with strong segment growth and capital returns.MRSH
Q1 202519 Dec 2025 - Strong 2024 results, robust governance, and key votes on directors, pay, auditor, and equity plan.MRSH
Proxy Filing1 Dec 2025